Header Logo

Sarah Hughes

Concepts (112)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Clinical Trials as Topic
6
2014
439
1.190
Why?
Drug Industry
2
2014
39
0.700
Why?
Data Interpretation, Statistical
5
2012
191
0.600
Why?
Dideoxynucleosides
4
2010
9
0.540
Why?
Anti-HIV Agents
4
2012
153
0.500
Why?
Information Dissemination
1
2014
111
0.410
Why?
Postoperative Care
1
2013
115
0.400
Why?
Patient Dropouts
1
2012
47
0.390
Why?
Preoperative Care
1
2013
180
0.380
Why?
Surgical Procedures, Operative
1
2013
137
0.370
Why?
HLA-B Antigens
2
2008
13
0.370
Why?
Recovery of Function
1
2013
271
0.370
Why?
Drug Hypersensitivity
2
2008
28
0.360
Why?
HIV Infections
5
2012
914
0.350
Why?
Aging
1
2013
710
0.280
Why?
Anniversaries and Special Events
1
2007
14
0.270
Why?
Societies, Scientific
1
2007
32
0.270
Why?
Genital Neoplasms, Female
1
2005
17
0.240
Why?
Research Design
3
2012
556
0.200
Why?
Sample Size
2
2012
62
0.170
Why?
History, 20th Century
2
2007
224
0.120
Why?
Uterine Cervical Neoplasms
2
2007
135
0.120
Why?
Humans
14
2014
59479
0.110
Why?
Online Systems
1
2014
19
0.110
Why?
Access to Information
1
2014
30
0.110
Why?
Confidentiality
1
2014
52
0.110
Why?
Research Personnel
1
2014
92
0.100
Why?
Patient Positioning
1
2013
44
0.100
Why?
Myocardial Infarction
2
2009
862
0.100
Why?
Delirium
1
2013
54
0.100
Why?
Wound Healing
1
2013
175
0.090
Why?
Pain, Postoperative
1
2013
141
0.090
Why?
Venous Thromboembolism
1
2013
145
0.090
Why?
Government Agencies
1
2011
10
0.090
Why?
Pain Management
1
2013
146
0.090
Why?
Drug and Narcotic Control
1
2011
28
0.090
Why?
Lamivudine
1
2010
7
0.090
Why?
Cooperative Behavior
1
2012
210
0.090
Why?
Organophosphonates
1
2010
21
0.090
Why?
Deoxycytidine
1
2010
40
0.090
Why?
Adenine
1
2010
49
0.090
Why?
Bone Density
1
2010
129
0.080
Why?
Patient Compliance
1
2012
349
0.080
Why?
Patient Discharge
1
2013
492
0.080
Why?
Expert Testimony
1
2008
17
0.080
Why?
Drug Approval
1
2008
25
0.080
Why?
Angioplasty, Balloon, Coronary
1
2009
167
0.070
Why?
Statistics as Topic
1
2009
146
0.070
Why?
Patch Tests
1
2008
11
0.070
Why?
Pharmacogenetics
1
2008
23
0.070
Why?
Fibrinolytic Agents
1
2009
163
0.070
Why?
Reverse Transcriptase Inhibitors
1
2008
28
0.070
Why?
Thrombolytic Therapy
1
2009
184
0.070
Why?
Risk Factors
3
2013
4991
0.070
Why?
Models, Theoretical
1
2009
256
0.070
Why?
Genetic Testing
1
2008
127
0.070
Why?
Decision Support Techniques
1
2009
180
0.070
Why?
History, 21st Century
1
2007
162
0.060
Why?
Papillomavirus Vaccines
1
2007
67
0.060
Why?
Pelvic Exenteration
1
2005
1
0.060
Why?
Aged
5
2013
13426
0.060
Why?
Vulvar Neoplasms
1
2005
9
0.060
Why?
History, 19th Century
1
2005
43
0.060
Why?
Lymphatic Metastasis
1
2005
74
0.060
Why?
Sentinel Lymph Node Biopsy
1
2005
38
0.060
Why?
Lymph Node Excision
1
2005
38
0.060
Why?
Papillomavirus Infections
1
2007
120
0.060
Why?
Female
7
2013
30779
0.060
Why?
Endometrial Neoplasms
1
2005
53
0.060
Why?
Hysterectomy
1
2005
66
0.060
Why?
Neoplasm Invasiveness
1
2005
248
0.060
Why?
Combined Modality Therapy
1
2005
354
0.060
Why?
Periodicals as Topic
1
2007
166
0.060
Why?
Ovarian Neoplasms
1
2005
130
0.060
Why?
Neoplasm Staging
1
2005
448
0.060
Why?
Sensitivity and Specificity
1
2005
1097
0.050
Why?
Risk Assessment
1
2009
1927
0.050
Why?
Prospective Studies
1
2008
3072
0.040
Why?
Young Adult
3
2010
4277
0.030
Why?
Adolescent
3
2010
5854
0.030
Why?
Adult
4
2010
15704
0.020
Why?
Middle Aged
4
2010
16342
0.020
Why?
European Union
1
2011
11
0.020
Why?
Emtricitabine
1
2010
8
0.020
Why?
Tenofovir
1
2010
8
0.020
Why?
Absorptiometry, Photon
1
2010
74
0.020
Why?
Drug Combinations
1
2010
146
0.020
Why?
Europe
1
2010
182
0.020
Why?
Coronary Restenosis
1
2009
19
0.020
Why?
Bone and Bones
1
2010
136
0.020
Why?
United Kingdom
1
2009
66
0.020
Why?
Adverse Drug Reaction Reporting Systems
1
2009
45
0.020
Why?
Male
4
2010
27794
0.020
Why?
Coronary Angiography
1
2009
176
0.020
Why?
Genetic Markers
1
2008
116
0.020
Why?
Survival Rate
1
2009
801
0.020
Why?
Papillomaviridae
1
2007
58
0.020
Why?
Electrocardiography
1
2009
524
0.020
Why?
Antigens, Viral
1
2007
130
0.020
Why?
Vaccines, DNA
1
2007
96
0.020
Why?
Coronary Artery Disease
1
2009
274
0.020
Why?
Double-Blind Method
1
2008
713
0.020
Why?
Genotype
1
2008
619
0.020
Why?
Receptors, Antigen, T-Cell
1
2007
281
0.010
Why?
Follow-Up Studies
1
2009
2341
0.010
Why?
Dendritic Cells
1
2007
515
0.010
Why?
HIV-1
1
2008
692
0.010
Why?
Time Factors
1
2009
3619
0.010
Why?
Aged, 80 and over
1
2009
5128
0.010
Why?
Treatment Outcome
1
2009
5293
0.010
Why?
Retrospective Studies
1
2009
6088
0.010
Why?
Animals
1
2007
19677
0.000
Why?
Hughes's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (112)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_